Table 2 –
Descriptive preoperative characteristics of patients related to salvage lymph node dissection (sLND).
| Variable | Overall population (n = 189; 100%) |
|---|---|
| Time from RP to PSA rising (mo) | 22 (7, 38) |
| Type of PET/CT tracer, n (%) | |
| 11C-choline | 154 (81) |
| 68Ga-PSMA | 6 (3) |
| Unknown | 29 (16) |
| Ongoing ADT at the time of PET/CT, n (%) | |
| No | 98 (52) |
| Yes | 34 (18) |
| Unknown | 57 (30) |
| Site of positive spots at PET/CT, n (%) | |
| Pelvic | 113 (60) |
| Retroperitoneal | 18 (10) |
| Both | 27 (14) |
| Unknown | 31 (16) |
| Number of positive spots at PET/CT, n (%) | |
| 0 | 9 (5) |
| 1 | 91 (48) |
| 2 | 26 (14) |
| ≥3 | 38 (20) |
| Unknown | 25 (13) |
| Age at sLND (yr) | 65 (60, 70) |
| PSA level at sLND (ng/mL) | 2.5 (1.1, 5.4) |
ADT = androgen deprivation therapy; PSA = prostate-specific antigen; PSMA = prostate-specific membrane antigen; PET/CT = positron emission tomography/computed tomography; RP = radical prostatectomy.
All numbers are medians (interquartile range) and frequencies (proportions).